MedPath

METHOTREXATE SODIUM INJ 20MG

METHOTREXATE SODIUM INJ 20MG

Discontinued
DIN Number

00410195

Drug Class

Human

Market Date

Dec 31, 1977

Company
HC

lederle cyanamid canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00410195
AIG Number0107545003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01BA01 METHOTREXATE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular ,  Intravenous ,  Intrathecal
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

METHOTREXATE (METHOTREXATE SODIUM)Active
Strength: 20 MG / VIAL
Monograph: METHOTREXATE (METHOTREXATE SODIUM)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.